SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday

SOPHiA GENETICS (NASDAQ:SOPH) is anticipated to release its earnings data before the market opens on Tuesday, March 4th. Analysts expect SOPHiA GENETICS to post earnings of ($0.23) per share and revenue of $17.71 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

SOPHiA GENETICS Price Performance

SOPHiA GENETICS stock opened at $3.93 on Tuesday. SOPHiA GENETICS has a 52-week low of $2.70 and a 52-week high of $7.37. The stock has a market capitalization of $256.94 million, a price-to-earnings ratio of -3.61 and a beta of 1.03. The stock’s 50 day moving average price is $3.54 and its two-hundred day moving average price is $3.55. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.59 and a current ratio of 3.80.

Analysts Set New Price Targets

Separately, Craig Hallum began coverage on SOPHiA GENETICS in a research report on Wednesday, December 18th. They set a “buy” rating and a $11.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $7.40.

About SOPHiA GENETICS

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.